At a glance
- Originator Pfizer
- Class Small molecules
- Mechanism of Action Protein tyrosine kinase inhibitors; Src-Family kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 31 Jul 2000 No-Development-Reported for Cancer in USA (Unknown route)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 11 Dec 1998 New profile